Hall Christopher J, Sanderson Leslie E, Crosier Kathryn E, Crosier Philip S
Department of Molecular Medicine and Pathology, School of Medical Sciences, University of Auckland, Private Bag 92019, Auckland, New Zealand.
J Mol Med (Berl). 2014 Nov;92(11):1119-28. doi: 10.1007/s00109-014-1186-6. Epub 2014 Jun 25.
Metabolism and defense mechanisms that protect against pathogens are two fundamental requirements for the survival of multicellular organisms. Research into metabolic disease has revealed these core mechanisms are highly co-dependent. This emerging field of research, termed immunometabolism, focuses on understanding how metabolism influences immunological processes and vice versa. It is now accepted that obesity influences the immune system and that obesity-driven inflammation contributes to many diseases including type 2 diabetes, cardiovascular disease and Alzheimer's disease. The immune response requires the reallocation of nutrients within immune cells to different metabolic pathways to satisfy energy demands and the production of necessary macromolecules. One aspect of immunometabolic research is understanding how these metabolic changes help regulate specific immune cell functions. It is hoped that further understanding of the pathways involved in managing this immunological-metabolic interface will reveal new ways to treat metabolic disease. Given their growing status as principle drivers of obesity-associated inflammation, monocytes/macrophages have received much attention when studying the consequences of inflammation within adipose tissue. Less is known regarding how metabolic changes within macrophages (metabolic reprogramming) influence their immune cell function. In this review, we focus on our current understanding of how monocytes/macrophages alter their intracellular metabolism during the immune response and how these changes dictate specific effector functions. In particular, the immunomodulatory functions of mitochondrial metabolism and mitochondrial reactive oxygen species. We also highlight how the attributes of the zebrafish model system can be exploited to reveal new mechanistic insights into immunometabolic processes.
新陈代谢和抵御病原体的防御机制是多细胞生物生存的两个基本要求。对代谢性疾病的研究表明,这些核心机制高度相互依赖。这个新兴的研究领域称为免疫代谢,专注于理解新陈代谢如何影响免疫过程,反之亦然。现在人们已经认识到肥胖会影响免疫系统,并且肥胖引发的炎症会导致包括2型糖尿病、心血管疾病和阿尔茨海默病在内的许多疾病。免疫反应需要将免疫细胞内的营养物质重新分配到不同的代谢途径,以满足能量需求和产生必要的大分子。免疫代谢研究的一个方面是理解这些代谢变化如何帮助调节特定免疫细胞的功能。人们希望进一步了解参与管理这种免疫 - 代谢界面的途径将揭示治疗代谢性疾病的新方法。鉴于单核细胞/巨噬细胞作为肥胖相关炎症的主要驱动因素的地位日益凸显,在研究脂肪组织内炎症的后果时,它们受到了很多关注。关于巨噬细胞内的代谢变化(代谢重编程)如何影响其免疫细胞功能,人们了解得较少。在这篇综述中,我们专注于目前对单核细胞/巨噬细胞在免疫反应过程中如何改变其细胞内代谢以及这些变化如何决定特定效应功能的理解。特别是线粒体代谢和线粒体活性氧的免疫调节功能。我们还强调了如何利用斑马鱼模型系统的特性来揭示免疫代谢过程的新机制见解。